Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats

Diabetes

Volumn 46, Issue 2, 1997, Pages 209-214

  Sainsbury, Amanda ^a   Cusin, Isabelle ^a   Rohner Jeanrenaud, Françoise ^a   Jeanrenaud, Bernard ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; GLUCOSE; INSULIN; MESSENGER RNA; NEUROPEPTIDE Y; TRIACYLGLYCEROL;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WHITE ADIPOSE TISSUE;

EID: 0030914760     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.209     Document Type: Article

References (48)

1. Nosadini R, Del Prato S, Tiengo A, Valerio A, Muggeo M, Opocher G, Mantero F, Duner E, Marescotti C, Mollo F, Belloni F: Insulin resistance in Cushing's syndrome. J Clin Endocrinol Metab 57:529-536, 1983
2. Terrettaz J, Assimacopoulos-Jeannet F, Jeanrenaud B: Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese fa/fa rats. Endocrinology 118:674-678, 1986
3. Coleman DL: Classical diabetes models: past lessons and potential new therapies. In Frontiers in Diabetes Research: Lessons From Animal Diabetes II. Shafrir E, Renold AE, Eds. London, Libbey, 1988, p. 253-256
4. Ohshima K, Shargill NS, Chan TM, Bray GA: Adrenalectomy reverses insulin resistance in muscle from obese (ob/ob) mice. Am J Physiol 246:E193-E197, 1984
5. Björntorp P: The regulation of adipose tissue distribution in humans. Int J Obes 20:291-302, 1996
6. Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B: Involvement of non-esterifled fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36:899-906, 1993
7. McMahon M, Gerich J, Rizza R: Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 4:17-30, 1988
8. Fletcher JM, McKenzie N: The parasympathetic nervous system and glucocorticoid-mediated hyperinsulinaemia in the genetically obese (fa/fa) Zucker rat. J Endocrinol 118:87-92, 1988
9. Freedman MR, Horwitz BA, Stern JS: Effect of adrenalectomy and glucocorticoid replacement on development of obesity. Am J Physiol 250:R595-R607, 1986
10. Walker HC, Romsos DR: Glucocorticoids in the CNS regulate BAT metabolism and plasma insulin in ob/ob mice. Am J Physiol 262:E110-E117, 1992
11. Freedman MR, Castonguay TW, Stern JS: Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats. Am J Physiol 249:R584-R594, 1985
12. Castonguay TW, Dallman MF, Stern JS: Some metabolic and behavioral effects of adrenalectomy on obese Zucker rats. Am J Physiol 251:R923-R933, 1986
13. Trocki O, Baer DJ, Castonguay TW: Comparison of effects of adrenalectomy and RU-486 in rats given a choice of maintenance diet and fat supplement. Am J Physiol 269:R708-R719, 1995
14. Tokunaga K, Fukushima M, Lupien JR, Bray GA, Kemnitz JW, Schemmel R: Effects of food restriction and adrenalectomy in rats with VMH or PVH lesions. Physiol Behav 45:1131-1137, 1989
15. King BM, Smith RL: Hypothalamic obesity after hypophysectomy or adrenalectomy: dependence on corticosterone. Am J Physiol 249:R522-R526, 1985
16. Debons AF, Zurek LD, Tse CS, Abrahamsen S: Central nervous system control of hyperphagia in hypothalamic obesity: dependence on adrenal glucocorticoids. Endocrinology 118:1678-1681, 1986
17. Leibowitz SF: Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes. Brain Res Bull 27:333-337, 1991
18. Dryden S, Frankish H, Wang Q, Williams G: Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24:293-308, 1994
19. Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, Jeanrenaud B: Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinology 63:318-326, 1996
20. McDonald JK, Koenig JI: Neuropeptide Y actions on reproductive and endocrine functions. In The Biology of Neuropeptide Y and Related Peptides. Colmers WF, Wahlestedt C, Eds. New Jersey, Humana, 1993, p. 419-456
21. Bchini-Hooft van Huijsduijnen O, Rohner-Jeanrenaud F, Jeanrenaud B: Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats: potential regulation thereof by corticotropinreleasing factor. J Neuroendocrinol 5:381-386, 1993
22. Williams G, Shellard L, Lewis DE, McKibbin PE, McCarthy HD, Koeslag G, Russell JC: Hypothalamic neuropeptide Y disturbances in the obese (cp/cp)JCR:LA corpulent rat. Peptides 13:537-540, 1992
23. Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, MacKellar W, Rosteck PR, Schoner B, Smith D, Tinsley FC, Zhang XY, Heiman M: The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530-532, 1995
24. Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B: Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37:1202-1208, 1994
25. Larsen PJ, Jessop DS, Chowdrey HS, Lightman SL, Mikkelsen JD: Chronic administration of glucocorticoids directly upregulates pro-neuropeptide Y and Y1-receptor mRNA levels in the arcuate nucleus of the rat. J Neuroendocrinol 6:153-159, 1994
26. White BD, Dean RG, Edwards GL, Martin RJ: Type II corticosteroid receptor stimulation increases NPY gene expression in basomedial hypothalamus of rats. Am J Physiol 266:R1523-R1529, 1994
27. McKibbin PE, Cotton SJ, McCarthy HD, Williams G: The effect of dexamethasone on neuropeptide Y concentrations in specific hypothalamic regions. Life Sci 51:1301-1307, 1992
28. White BD, Dean RG, Martin RJ: Adrenalectomy decreases neuropeptide Y mRNA levels in the arcuate nucleus. Brain Res Bull 25:711-715, 1990
29. Dean RG, White BD: Neuropeptide Y expression in rat brain: effects of adrenalectomy. Neurosci Lett 114:339-344, 1990
30. Corder R, Pralong F, Turnill D, Saudan P, Muller AF, Gaillard RC: Dexamethasone treatment increases neuropeptide Y levels in rat hypothalamic neurones. Life Sci 43:1879-1886, 1988
31. Ferré P, Leturque A, Burnol AF, Pénicaud L, Girard J: A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J 228:103-110, 1985
32. James DE, Burleigh KM, Kraegen EW: In vivo glucose metabolism in individual tissues of the rat. J Biol Chem 261:6366-6374, 1986
33. Terrettaz J, Cusin I, Etienne J, Jeanrenaud B: In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats. Int J Obes 18:9-15, 1994
34. Gwosdow-Cohen A, Chen CL, Besch EL: Radioimmunoassay (RIA) of serum corticosterone in rats. Proc Soc Exp Biol Med 170:29-34, 1982
35. Sainsbury A, Cusin I, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B: Intracerebroventricular administration of neuropeptide Y to normal rats increases obese gene expression in white adipose tissue. Diabetotogia 39:353-356, 1996
36. Stanley BG, Lanthier D, Chin AS, Leibowitz SF: Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone. Brain Res 501:32-36, 1989
37. Kalra SP, Dube MG, Kalra PS: Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: effects of adrenalectomy and cholecystokinin. Peptides 9:723-728, 1988
38. Morley JE, Levine AS, Gosnell BA, Kneip J, Grace M: Effect of neuropeptide Y on ingestive behaviors in the rat. Am J Physiol 252:R599-R607, 1987
39. Spinedi E, Giacomini M, Jacquier MC, Gaillard RC: Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorucoid action. Neuroendocrinology 53:160-170, 1991
40. Tempel DL, Leibowitz SF: Glucocorticoid receptors in PVN: interactions with NE, NPY, and GAL in relation to feeding. Am J Physiol 265:E794-E800, 1993
41. Tempel DL, Leibowitz SF: Adrenal steroid receptors: interactions with brain neuropeptide systems in relation to nutrient intake and metabolism. J Neuroendocrinol 6:479-501, 1994
42. Rohner-Jeanrenaud F: A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. Int J Obes 19:517-534, 1995
43. Freedman MR, Stern JS, Reaven GM, Mondon CE: Effects of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats. Horm Metab Res 18:296-298, 1986
44. Shikama H, Chu DTW, Exton JH: Modulation by adrenalectomy and fasting of insulin effects in perfused hindlimb muscle. Am J Physiol 242:E323-E329, 1982
45. Cusin I, Terrettaz J, Rohner-Jeanrenaud F, Zarjevski N, Assimacopoulos-Jeannet F, Jeanrenaud B: Hyperinsulinemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology 127:3246-3248, 1990
46. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-432, 1994
47. De Vos P, Saladin R, Auwerx J, Steels B: Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 270:15958-15961, 1995
48. Murakami T, Iida M, Shima K: Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem. Biophys Res Commun 214:1260-1267, 1995